Glenmark Pharmaceuticals Limited (GLENMARK)
₹2,172
INR+353.20(+19.42%)
As of July 11, 2025 9:51:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹51719.32 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹51736.88 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
49.45
Forward P/E
Price to Earnings ratio based on forecasted earnings
43.09
PEG Ratio
Price/Earnings to Growth ratio
43.09
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.85
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
66.18%
Operating Margin
Operating income as a percentage of revenue
13.69%
Return on Equity
Net income as a percentage of shareholders' equity
12.54%
Revenue (TTM)
Total revenue over trailing 12 months
₹13435.46 Cr-16.1%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹2092.28 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹37.02+6.768089983905867%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1705.23 Cr
Total Debt
Total short-term and long-term debt
₹2472.67 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
27.94%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1275.5 - ₹1879.4
Beta
Measure of stock's volatility compared to the market
0.20
Shares Outstanding
Total number of shares issued by the company
₹28.22 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.55%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.14%
Payout Ratio
Percentage of earnings paid as dividends
6.74%
